Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 September 2007, Vol. 110, No. 5, pp. 1403-1404.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coppes, R. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Coppes, R. P.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

HEMATOPOIESIS

Comment on Boyle et al, page 1466

SOCS box: fine-tuning inflammatory responses

Robert P. Coppes

UNIVERSITY OF GRONINGEN

Suppressor of cytokine signaling 3 (SOCS3) protein regulates the response of bone marrow cells to granulocyte colony-stimulating factor (G-CSF). Boyle and colleagues report involvement of the SOCS3 box of SOCS3 in the in vivo regulation of inflammatory responses.

Blood cell production and mobilization, which are tightly regulated by hematopoietic growth factors and cytokines, are negatively influenced by suppressor of cytokine signaling (SOCS) proteins. SOCS proteins regulate cytokine receptor turnover.1 One of these, the SOCS3 protein, is a major physiological regulator of G-CSF signaling. It contains a central SH2 domain, which recognizes the activated G-CSF receptor, and a highly conserved C-terminal region, the so-called SOCS3 box, which recruits E3 ligase activity leading to ubiquitination and degradation of the receptor.2 To elucidate the physiological role of the SOCS3 box of SOCS3 in the regulation of G-CSF signaling and response to inflammatory stimuli, Boyle and colleagues generated mice with a deletion of only the SOCS3 box. Unlike a full knockout of the SOCS3 gene that results in embryonic lethality3 and deletion of SOCS3 specifically in hematopoietic cells, which leads to severe inflammatory disease4 under normal conditions, deletion only of the SOCS3 box resulted in a slight neutrophilia. However, in response to G-CSF, an increased transcription and prolonged activation of STAT3, which is required for the induction of SOCS3 in response to G-CSF, was observed in primary bone marrow cells (BMCs) of SOCS3-box–deleted mice compared with wild-type BMCs. Moreover, SOCS3-box–negative BMCs were hyperresponsive to G-CSF, which led to increased BMC proliferation and mobilization and granulopoiesis. Interestingly, a more fulminant arthritis was also observed in SOCS3-box–deleted mice after IL-1 injection. Because this model is dependent on G-CSF, this response is probably due to exaggerated G-CSF responsiveness.

The data show that the SOCS3 box of SOCS3 plays a physiologically important modulatory role in G-CSF–induced BMC responses, most likely due to a retarded G-CSF receptor breakdown.1

Because the normally low levels of G-CSF are up-regulated after infection, a potentially therapeutic role may be possible for the use SOCS3 proteins. Gene delivery of whole SOCS3 has already been shown to protect against lethal endotoxic shock,5 tempering inflammatory responses in mice. Although difficult to achieve, specific targeting of this SOCS3 box may allow more subtle modulation of inflammatory responses. Moreover, modulation of SOCS boxes of the SOCS protein family may be useful in studying the regulation of other cytokine-receptor signaling pathways. Therefore, this and future studies may be of aid in designing specific SOCS-box–related therapies that may be effective in autoimmune and other inflammation-related diseases.

Footnotes

Conflict-of-interest disclosure: The author declares no competing financial interests. {blacksquare}

REFERENCES

  1. Irandoust MI, Aarts LH, Roovers O, et al. Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J 2007; 26:1782–1793.[CrossRef][Medline] [Order article via Infotrieve]

  2. Kile BT, Schulman BA, Alexander WS, et al. The SOCS box: a tale of destruction and degradation. Trends Biochem Sci 2002; 27:235–241.[CrossRef][Medline] [Order article via Infotrieve]

  3. Roberts AW, Robb L, Rakar S, et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A 2001; 98:9324–9329.[Abstract/Free Full Text]

  4. Croker BA, Metcalf D, Robb L, et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 2004; 20:153–165.[CrossRef][Medline] [Order article via Infotrieve]

  5. Fang M, Dai H, Yu G, Gong F. Gene delivery of SOCS3 protects mice from lethal endotoxic shock. Cell Mol Immunol 2005; 2:373–377.[Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo
Kristy Boyle, Paul Egan, Steven Rakar, Tracy A. Willson, Ian P. Wicks, Donald Metcalf, Douglas J. Hilton, Nicos A. Nicola, Warren S. Alexander, Andrew W. Roberts, and Lorraine Robb
Blood 2007 110: 1466-1474. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coppes, R. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Coppes, R. P.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020